Comparison of Adding EMEND to PONV/PDNV Treatment Regimen
Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study is looking at whether the addition of a fairly new drug for the treatment of
post-operative nausea and vomiting (PONV) and post-discharge nausea and vomiting(PDNV)will
provide added efficacy if added to 2 drugs that are already used as a standard of care for
PONV and PDNV.
The patients that will be looked at will be deemed at higher risk for PONV and PDNV based on
the procedure they are having done and/or on patient risk factors.